UAMS’s Johann receives $1.4 million for lung cancer clinical trials

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Donald Johann Jr. has been awarded a $1.47 million grant from FDA to continue a clinical trial to determine if new approaches can be developed to monitor and screen for lung cancer with a blood test.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login